Your session is about to expire
← Back to Search
AI-Powered Eye Exam for Diabetes (ACCESS2 Trial)
N/A
Recruiting
Led By Risa M Wolf, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Meets American Diabetes Association (ADA) criteria for diabetic retinopathy screening: Diagnosis of Type 1 diabetes for ≥3 years, and age 11 or in puberty
Diagnosis of Type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
ACCESS2 Trial Summary
This trial will test if a nonmydriatic fundus camera, which uses autonomous artificial intelligence software, can increase screening for diabetic retinopathy in underserved youth with diabetes.
Who is the study for?
This trial is for young people with Type 1 diabetes for at least 3 years, aged 11 or older and in puberty, or those diagnosed with Type 2 diabetes. It's aimed at helping underserved youth who haven't had a diabetic eye exam in the past year.Check my eligibility
What is being tested?
The study tests if an AI-powered camera can help screen more kids with diabetes for eye problems caused by their condition (diabetic retinopathy) when used during regular care visits.See study design
What are the potential side effects?
Since this intervention involves a non-invasive imaging test using a camera, there are no direct side effects associated with medications or invasive procedures.
ACCESS2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had Type 1 diabetes for 3+ years and am at least 11 years old or in puberty.
Select...
I have been diagnosed with Type 2 diabetes.
ACCESS2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion screened for diabetic retinopathy
Secondary outcome measures
Diagnostic Accuracy
Percentage of agreement in interpretation of retinal images
ACCESS2 Trial Design
1Treatment groups
Experimental Treatment
Group I: Diabetic Retinopathy Exam at the point of careExperimental Treatment1 Intervention
Participants will undergo a point of care diabetic retinopathy eye exam using autonomous AI. Those that test positive will be referred to Eye Care Provider for dilated eye exam.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Point of Care Autonomous AI diabetic retinopathy exam
2021
N/A
~170
Find a Location
Who is running the clinical trial?
Juvenile Diabetes Research FoundationOTHER
232 Previous Clinical Trials
141,284 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,260 Previous Clinical Trials
14,820,280 Total Patients Enrolled
National Eye Institute (NEI)NIH
546 Previous Clinical Trials
1,401,428 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had Type 1 diabetes for 3+ years and am at least 11 years old or in puberty.You had an eye exam for diabetes in the past year.I have been diagnosed with Type 2 diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: Diabetic Retinopathy Exam at the point of care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies still remaining for this particular experiment?
"According to clinicaltrials.gov, this medical trial has been open for recruitment since July 11th of 2022 and was recently updated on the 14th."
Answered by AI
Does your research protocol incorporate participants who are 25 and older?
"Patients aged 8 to 21 are eligible for inclusion in this trial, as outlined by the predetermined eligibility criteria."
Answered by AI
To whom is eligibility for this clinical research extended?
"This investigation is enrolling 500 patients aged 8 to 21 with type 2 diabetes mellitus. The main requirements for participants are a diagnosis of Type 1 diabetes lasting at least 3 years and age 11 or beyond, as well as being diagnosed with Type 2 Diabetes."
Answered by AI
How many participants are currently being accepted into this research program?
"Affirmative. According to clinicaltrials.gov, the trial posted on July 11th 2022 is actively recruiting participants. 500 patients are expected at a single medical facility for the duration of this research study."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger